BioAge Labs (BIOA) Short term Debt (2023 - 2026)

BioAge Labs has disclosed Short term Debt across 4 years of filings, most recently posting $1.2 million for Q1 2026.

• In Q1 2026, Short term Debt fell 80.68% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (down 80.68% YoY), while the FY2025 annual figure was $2.6 million, down 55.87% from the prior year.
• Short term Debt came in at $1.2 million for Q1 2026 at BioAge Labs, down from $2.6 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $6.0 million in Q4 2023 to a low of $1.2 million in Q1 2026.
• Average Short term Debt over 4 years is $4.7 million, with a median of $5.8 million recorded in 2023.
• Year-over-year, Short term Debt changed 0.0% in 2024 and slumped 80.68% in 2026.
• Over 4 years, Short term Debt stood at $6.0 million in 2023, then changed by 0.0% to $6.0 million in 2024, then plunged by 55.87% to $2.6 million in 2025, then slumped by 56.23% to $1.2 million in 2026.
• Per Business Quant data, the three most recent Short term Debt figures were $1.2 million in Q1 2026, $2.6 million in Q4 2025, and $4.1 million in Q3 2025.